Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Co-Diagnostics sees record 3Q revenue of $30.1M on Logix Smart coronavirus test sales
04:31pm, Thursday, 11'th Nov 2021
Co-Diagnostics (NASDAQ:CODX) Inc has announced record third-quarter 2021 revenue of $30.1 million, a 38% year-over-year increase, which the company attributed primarily to sales of its Logix Smart cor
Co-Diagnostics says it will be awarded the 'Innovation Impact Award' at the 2021 BioUtah Life Sciences awards
07:33am, Thursday, 11'th Nov 2021
Co-Diagnostics (NASDAQ:CODX) Inc has said it will be awarded the 'Innovation Impact Award' at the 2021 BioUtah Life Sciences awards which will be presented on Friday, November 12, 2021, during a virtu
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform
07:42am, Friday, 05'th Nov 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:
Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for
04:47pm, Thursday, 04'th Nov 2021
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Co-Diagnostics says its Logix Smart COVID-19 test has been approved for sale in the UK
11:25am, Thursday, 04'th Nov 2021
Co-Diagnostics (NASDAQ:CODX) Inc has announced that its Logix Smart SARS-CoV-2 2-Gene multiplex test is now available for sale in the UK after being validated according to the United Kingdom Health
Co-Diagnostics says its CoSara JV wins clearance in India for Saragene Dengue and Chikungunya Multiplex Test
12:19pm, Wednesday, 06'th Oct 2021
Co-Diagnostics Inc., revealed that CoSara Diagnostics Pvt Ltd., its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization (CD
Co-Diagnostics says it CoSara JV wins clearance in India for Saragene Dengue and Chikungunya Multiplex Test
12:13pm, Wednesday, 06'th Oct 2021
Co-Diagnostics Inc., revealed that CoSara Diagnostics Pvt Ltd., its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization (CD
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test
10:54am, Wednesday, 06'th Oct 2021
SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular dia
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform
05:54am, Thursday, 30'th Sep 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform for the masses
05:53am, Thursday, 30'th Sep 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:
Co-Diagnostics, Inc. has said it will be introducing its upcoming at-home and point-of-care PCR device at a press conference at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo being held
Co-Diagnostics announces corporate rebranding after period of transformative growth and expansion
10:47am, Thursday, 23'rd Sep 2021
Co-Diagnostics Inc. is rebranding its image to better reflect its growing scope, mission, and upcoming expansion into new diagnostics verticals.
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
09:30am, Thursday, 23'rd Sep 2021
SALT LAKE CITY, Sept. 23, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular d
Co-Diagnostics says its Logix Smart ABC Test is authorized for use in Mexico
10:56am, Tuesday, 21'st Sep 2021
Co-Diagnostics Inc has announced that its Logix Smart Influenza A/Influenza B/COVID-19 "ABC" Test has been approved for sale in Mexico by the Mexican Department of Epidemiology (InDRE) after the depa
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico
09:30am, Tuesday, 21'st Sep 2021
SALT LAKE CITY, Sept. 21, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced
